Immunogenicity of HIV-1 gp140 - microbicide mixtures in mice using a vaginal delivery model

Παρόμοια τεκμήρια

• P14-06. Phase 1 safety and immunogenicity randomised controlled trial of a vaginal gp140 vaccine
  ανά: Giemza E, κ.ά.
  Έκδοση: (2009-10-01)
• Vaginal Delivery of a Recombinant HIV-1 Clade-C Trimeric gp140 within Novel Rheologically Structured Vehicles Induces Specific Immune Responses
  ανά: Curran, R, κ.ά.
  Έκδοση: (2008)
• Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer.
  ανά: Krashias, G, κ.ά.
  Έκδοση: (2010)
• A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment.
  ανά: Wegmann, F, κ.ά.
  Έκδοση: (2011)
• A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment
  ανά: Wegmann, F, κ.ά.
  Έκδοση: (2011)